Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.
Resistin also known as adipose tissue-specific secretory factor, Resistin hormone has been identified that links obesity to type 2 diabetes and is encoded by the RETN gene. It is first identified in mice, it has also been found in humans.
Type 2 diabetes has long been observed to be associated with obesity. Insulin resistance is the hallmark of type 2 diabetes and is manifested all over the body.
Circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity. Administration of anti-resistin antibody improves blood sugar and insulin action in mice with diet-induced obesity.
Journal of Obesity and Diabetes emphasize in publishing the original scholarly articles related to Obesity and Diabetes worldwide. The journal follows rapid review process with the Eminent Editorial Board
Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Resistin, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.
Related article links for Resistin will appear here as matching content is published in Journal of Obesity and Diabetes (ISSN: 2638-812X). Readers can also browse the journal archive and current issue for connected research.
